Literature DB >> 25965567

Convert and conquer: the strategy of chronic myelogenous leukemic cells.

Simón Méndez-Ferrer1, María García-Fernández2, Carlos L F de Castillejo2.   

Abstract

Emerging evidence is contributing to explain how leukemias disrupt normal blood cell production. In this issue of Cancer Cell, Welner and colleagues show that, during the development of chronic myeloid leukemia, mutated cells transform normal hematopoietic progenitors into "leukemic like" cells through IL-6 secretion, proposing a new cellular target.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25965567     DOI: 10.1016/j.ccell.2015.04.012

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  6 in total

1.  Aging as a driver of leukemogenesis.

Authors:  Thomas McKerrell; George S Vassiliou
Journal:  Sci Transl Med       Date:  2015-09-23       Impact factor: 17.956

2.  AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome.

Authors:  Peng Li; Thomas White; Wei Xie; Wei Cui; Deniz Peker; Gang Zeng; Huan-You Wang; Jennie Vagher; Sara Brown; Margaret Williams; Tibor Kovacsovics; Jay L Patel
Journal:  Leukemia       Date:  2021-10-20       Impact factor: 12.883

Review 3.  Bone marrow niches in haematological malignancies.

Authors:  Simón Méndez-Ferrer; Dominique Bonnet; David P Steensma; Robert P Hasserjian; Irene M Ghobrial; John G Gribben; Michael Andreeff; Daniela S Krause
Journal:  Nat Rev Cancer       Date:  2020-02-28       Impact factor: 60.716

4.  HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: a new therapeutic target?

Authors:  Teresa L Ramos; Luis Ignacio Sánchez-Abarca; Alba Redondo; Ángel Hernández-Hernández; Antonio M Almeida; Noemí Puig; Concepción Rodríguez; Rebeca Ortega; Silvia Preciado; Ana Rico; Sandra Muntión; José Ramón González Porras; Consuelo Del Cañizo; Fermín Sánchez-Guijo
Journal:  Oncotarget       Date:  2017-04-25

5.  The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.

Authors:  Dorian Forte; Valentina Salvestrini; Giulia Corradi; Lara Rossi; Lucia Catani; Roberto M Lemoli; Michele Cavo; Antonio Curti
Journal:  Oncotarget       Date:  2017-01-10

6.  Role of autoimmune hemolytic anemia as an initial indicator for chronic myeloid leukemia: A case report.

Authors:  Xiang Li; Sisi Cai; Zhaodong Zhong; Hongxiang Wang; Li Wang; Yong You; Min Zhang
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.